phase readout
saveNCT07039162: Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma
RECRUITINGupdated 43m ago
community read0 votes
Sponsor: Ming-Yu Lien. Phase: PHASE2. Conditions: Esophageal Squamous Cell Carcinoma (ESCC), Locally Advanced Unresectable Esophageal Cancer
view source ↗
comments(0)
5-min edit window · permanent after that